Consensus Cloud Solutions, Inc. — FY 2023 Form 10-K
Reporting period: Fiscal year ended December 31, 2023. This is an annual report, not a standalone Q4 earnings report; the filing does not provide a clear set of Q4 2023 financial results. Dollar amounts below are in U.S. dollars.
Business context
Consensus provides subscription and usage-based secure information delivery software, principally cloud fax, to approximately 885,000 customer accounts in about 47 countries. Healthcare is its largest industry vertical. Corporate customers and SoHo customers generated $199.6 million and $162.9 million of 2023 revenue, respectively. Healthcare interoperability and data-extraction products are strategic growth initiatives, but the filing says these offerings beyond online fax currently contribute an immaterial portion of revenue.
Financial results and liquidity
| Metric | FY 2023 | FY 2022 |
|---|---|---|
| Revenue | $362.6 million | $362.4 million |
| Gross profit / margin | $294.2 million / 81% | $300.5 million / 83% |
| Operating income / margin | $147.2 million / 41% | $151.9 million / 42% |
| Net income | $77.3 million | $72.7 million |
| Diluted EPS | $3.94 | $3.64 |
| Cash from operations | $114.1 million | $83.1 million |
| Cash and cash equivalents at year-end | $88.7 million | $94.2 million |
Revenue was essentially flat: Corporate revenue grew 3.9% to $199.6 million, while SoHo revenue fell $7.3 million to $162.9 million. Cost of revenue increased 10% to $68.3 million, contributing to the gross-margin decline. Operating expenses were broadly stable. Net income increased despite lower operating income, with interest expense declining to $45.4 million from $51.4 million; 2023 also included $3.7 million of interest income and a $4.8 million gain on debt extinguishment. The effective tax rate was 25.1%, versus 26.5%.
Investing activities used $40.5 million, primarily for property, equipment and software development; financing activities used $81.7 million, principally for debt and share repurchases. Property and equipment rose to $81.2 million, including substantial capitalized internal-use software costs. Current assets were $125.2 million and current liabilities $71.4 million. Of year-end cash, $74.2 million was held in foreign jurisdictions and $14.5 million domestically.
Year-end senior-note principal was $742.4 million: $280.0 million of 6.0% notes due 2026 and $462.4 million of 6.5% notes due 2028. The company had repurchased $62.6 million of principal under its debt repurchase program by year-end; it subsequently paid $28.6 million to repurchase another $30.4 million of principal. A $25 million revolving facility was undrawn. Management stated that cash and operating cash flow should be sufficient for anticipated needs for at least the next 12 months. The company reported compliance with debt covenants.
Changes, outlook and notable matters
- Customer accounts declined to 885,000 from 994,000, mainly reflecting a reduction in SoHo accounts. Corporate accounts increased to 54,000 from 52,000. Average monthly revenue per account rose to $32.16 from $29.07, while consolidated monthly churn improved to 3.43% from 3.61%.
- Management’s strategy is to grow Corporate secure information exchange, develop healthcare interoperability products, optimize SoHo, and prioritize profitability and cash generation, with targeted acquisitions as opportunities arise. The filing provides no specific numeric revenue or earnings guidance.
- The company completed its voluntary disclosure agreement process for historical sales taxes in Q4 2023. It recorded $2.0 million of sales-tax expense in 2023 and reported a $7.3 million sales-tax liability at year-end; taxing authorities could still challenge its positions or calculations.
- Previous material weaknesses in internal control over financial reporting were reported as remediated; management and the independent auditor concluded controls were effective as of December 31, 2023. The auditor identified capitalization of internal-use software development costs as a critical audit matter because determining which costs qualify requires management judgment.
- Key risks include dependence on cloud fax for substantially all revenue and operating income; execution and adoption risks for newer healthcare interoperability products; competition and technological change; cybersecurity, privacy and regulatory exposure; and substantial debt-service requirements. The filing says no cybersecurity incident had materially affected, or was reasonably likely to materially affect, the business as of the report date.
Important facts for investors to verify
- Whether Corporate growth and newer healthcare products can offset continued SoHo customer and revenue declines.
- Debt repayment pace, refinancing capacity and the effect of the 2026 and 2028 maturities on cash available for investment and repurchases.
- Cash accessibility and potential tax or other constraints given that most year-end cash was held outside the United States.
- Whether the $7.3 million sales-tax liability and uncertain tax positions adequately cover potential assessments.
- Whether capitalized software spending translates into product adoption and returns, and whether remediated controls remain effective.